A Trump administration crackdown on workers' routine expenses is upending work across the government, according to affected ...

With its strengthened leadership, the Galway medtech is aiming for a strong launch in the US market in the next 18 months.

"Massachusetts’ economy depends upon a vibrant Eds & Meds enterprise," U.S. Rep. Jake Auchincloss, D-4th District, said.

The founding director of the FDA’s Office of Biotechnology writes that, with FDA approval of medications ultimately vested ...

Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...

Deciding which risk to tolerate has long been the F.D.A.’s role, but rising external pressures are making that decision more ...

February is the shortest month, but there was still plenty of time for a rush of pharma and biotech hires, including a number ...

At the recent CBER agency workshop on cell therapies and tissue-based products, a few surprising ideas discussed could have ...

SymPhysis raised €2.8m in its latest funding round and expects to close a further €3.7m from a combination of current and new ...

The global blood banking equipment market is on track for significant expansion, with sales expected to climb from USD 16,322.1 million in 2024 to USD 25,591.4 million by 2034, reflecting a 4.6% ...

The FDA has relied on food companies for decades to determine whether their ingredients are safe. Some chemicals and ...